Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2003
10/30/2003US20030203890 Administering a neurotrophic compound 2-pyrrolidinecarboxylate derivatives after prostate surgery as well as erectile dysfunction
10/30/2003US20030203405 Comprises 4-(4-((acetylamino-ethylcarbamoyl-methyl)-amino)-phenyoxy)butyric acid as building blocks for solid phase synthesis; microarrays
10/29/2003EP1357110A1 Synthesis for the preparation of porphobilinogen, the compound as such as stabilized salt and intermediates thereof
10/29/2003EP1356812A1 Medicines for treatment and prevention of neurogenic pain
10/29/2003EP1356811A1 Preventives or remedies for arthritis
10/29/2003EP1355879A1 Carboxamides as fungicides in agriculture
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355648A2 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a)
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003CN1452483A IL-8 receptor antagonists
10/28/2003US6639076 Such as 2-(2-amino-2-methylpropanoylamino)-n-(1-(2-oxo-1-phenyl-2-pyrrolidinylethyl -4-yl)-4-phenylbutanamide
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638979 Imidamide derivatives
10/28/2003US6638975 Treatment of breast cancer
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638952 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/25/2003CA2383390A1 Easily removalbe reagents for the mitsunobu reaction
10/23/2003WO2003087094A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
10/23/2003WO2003087084A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086605A2 Functionalized ionic liquids, and methods of use thereof
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003086385A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
10/23/2003WO2003055441A3 Medicaments
10/23/2003WO2003035616A3 Tyrosine kinase inhibitors
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199566 Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same
10/23/2003US20030199563 Heterocyclic containing biphenyl aP2 inhibitors and method
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199521 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
10/23/2003US20030199516 Methods of treating infection by drug resistant bacteria
10/23/2003US20030199498 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030198880 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
10/23/2003CA2482536A1 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2481202A1 Functionalized ionic liquids, and methods of use thereof
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354882A1 Dipeptidyl peptidase iv inhibitor
10/22/2003EP1354868A1 Perfluoronated cycle-containing tertiary amines used as a basis for gas-conveying emulsions and device for the production thereof
10/22/2003EP1354584A1 Preventives for arthritis
10/22/2003EP1353917A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
10/22/2003EP1353905A2 Piperidine/piperazine-type inhibitors of p38 kinase
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353639A1 Primary intermediates for oxidative coloration of hair
10/22/2003CN1451012A Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
10/22/2003CN1450999A Novel piperazine derivatives
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450055A Process for preparing C 60 pyrrolidine group derivative
10/22/2003CN1125046C Butadiene derivatives and process for preparing thereof
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635786 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
10/21/2003US6635668 Imidazoline receptor binding compounds
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003US6635620 Hydroxyproline derivatives
10/21/2003US6635417 Complex formation between DSDNA and oligomer of cyclic heterocycles
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084533A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/16/2003WO2003037271A3 Compounds, pharmaceutical compositions and methods of use therefor
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2001066534A3 Cyclic and bicyclic diamino histamine-3 receptor antagonists
10/16/2003US20030195364 Coupling N-benzyl-3-pyrrolidinamine compound with acyl halide; cyclization in presence of a base; reacting with triphenylphosphine to obtain phosphonium salt; reacting with di-tert. -butyl-dicarbonate under hydrogenation conditions
10/16/2003US20030195353 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo- tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195196 Pyrrolobenzodiazepines
10/16/2003US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder
10/16/2003US20030195110 Remaining donor atoms of the ligand are selected from the group consisting of C, N, P, As, O, S, and Se
10/16/2003US20030194371 Nuclear magnetic resonance (NMR) diagnosis and radiotherapy
10/16/2003US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2481026A1 N-`4-(2-imino-pyrrolidin-1-yl)phenyl!-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1351997A2 Improved productivity catalysts and microstructure control
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351963A1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
10/15/2003EP1351959A1 Novel pleuromutilin derivatives
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351938A1 Phenyl derivatives
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
1 ... 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 ... 404